Cornerstone Planning Group’s Benitec Biopharma BNTC Stock Holding History

Cornerstone Planning Group’s Portfolio BNTC Stock Details BNTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$526	Buy	+46	New	+$546	﹤0.01%	1681

Other funds holding BNTC

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Cornerstone Planning Group's BNTC Position: Q2 2026 in Review

Cornerstone Planning Group opened a new position in Benitec Biopharma (BNTC) in Q2 2026: 46 shares worth $526. The stake represents ﹤0.01% of the portfolio and ranks #1681 among its holdings.

15 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

Cornerstone Planning Group held 46 shares of Benitec Biopharma worth $526 as of Q2 2026.
Benitec Biopharma was a new Cornerstone Planning Group position in Q2 2026.
Benitec Biopharma made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #1681 holding.
15 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.